Oral presentation provides first look at new program, IMR-261, a novel, oral, clinic-ready nuclear factor erythroid 2-related factor 2 (Nrf2) activator SCD Townes mouse model demonstrates IMR-261 ...
United State, New York, March 11, 2025 (GLOBE NEWSWIRE) -- IMR Market Reports is pleased to announce the publication of its latest report, Ammunition Reloading Equipment Market. This in-depth analysis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback